Advertisement
News
Advertisement

Misonix Announces Update of Product Registration in Brazil

Fri, 08/05/2011 - 5:41am
Bio-Medicine.Org
<p>FARMINGDALE, N.Y., Aug. 5, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: <a rel="nofollow" target="_blank" href="http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=MSON"> MSON</a>), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has announced the completion of product registration for its BoneScalpel&#8482; Ultrasonic Bone Cutting System in Brazil. &#160;This follows the April 21, 2011, announcement of registration completion for the SonaStar&#174; Surgical Aspiration System in Brazil. Open market sales have commenced for the SonaStar and it is expected that BoneScalpel will follow in the near future. &#160;Brazil is the largest market for medical devices in Latin America.</p> <p>Both BoneScalpel and the SonaStar are exclusively distributed in Brazil by Neuro Orthopaedics Surgeries, based near Rio de Janeiro. The Company entered into a distribution agreement with Neuro Orthopaedics on February 3, 2010.</p> <p>The SonaStar is used for quick and efficient removal of both hard and soft tumors while sparing most vessels. &#160;In addition, OsteoSculpt&#8482; bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.</p> <p>The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. &#160;It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.</p> <p>"Misonix is pleased with the outcome of the lengthy registration process required by the health ministry in Brazil. &#160;Latin America is a geographic market segment that Misonix has targeted for near-term sales growth and Brazil has a featured role in that plan," said Michael A. McManus, Jr., Pre<br /><font style='display:none;'>'/&gt;"/&gt;</font><br /><table border="0" width="520"><tr></table>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading